Why is HealthEquity, Inc. ?
1
Healthy long term growth as Net Sales has grown by an annual rate of 12.36%
2
With a growth in Net Profit of 28.75%, the company declared Very Positive results in Apr 26
- OPERATING CASH FLOW(Y) Highest at USD 489.89 MM
- ROCE(HY) Highest at 11.06%
- INTEREST COVERAGE RATIO(Q) Highest at 1,128.73
3
With ROE of 10.40%, it has a very expensive valuation with a 3.31 Price to Book Value
- Over the past year, while the stock has generated a return of -13.68%, its profits have risen by 39.2% ; the PEG ratio of the company is 0.8
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Below par performance in long term as well as near term
- Along with generating -13.68% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you hold?
- Overall Portfolio exposure to HealthEquity, Inc. should be less than 10%
- Overall Portfolio exposure to Capital Markets should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Capital Markets)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is HealthEquity, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
HealthEquity, Inc.
-13.68%
-0.02
35.53%
S&P 500
25.41%
1.92
13.25%
Quality key factors
Factor
Value
Sales Growth (5y)
12.36%
EBIT Growth (5y)
32.43%
EBIT to Interest (avg)
2.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
20.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
4.24%
ROE (avg)
3.32%
Valuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
3.31
EV to EBIT
23.26
EV to EBITDA
15.80
EV to Capital Employed
2.76
EV to Sales
5.80
PEG Ratio
0.77
Dividend Yield
NA
ROCE (Latest)
11.88%
ROE (Latest)
10.40%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
14What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 489.89 MM
ROCE(HY)
Highest at 11.06%
INTEREST COVERAGE RATIO(Q)
Highest at 1,128.73
RAW MATERIAL COST(Y)
Fallen by -8.77% (YoY
NET SALES(Q)
Highest at USD 354.44 MM
OPERATING PROFIT(Q)
Highest at USD 142.08 MM
OPERATING PROFIT MARGIN(Q)
Highest at 40.09 %
PRE-TAX PROFIT(Q)
Highest at USD 93.53 MM
NET PROFIT(Q)
Highest at USD 70.25 MM
EPS(Q)
Highest at USD 0.82
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for HealthEquity, Inc.
Operating Cash Flow
Highest at USD 489.89 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Interest Coverage Ratio
Highest at 1,128.73
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
Highest at USD 354.44 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 142.08 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 40.09 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 93.53 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 70.25 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.82
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -8.77% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






